40 /100
MEDIUM RISK
Score updated Apr 13, 2026

QNCX

Quince Therapeutics, Inc. — Stock Dilution Tracker

Track QNCX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track QNCX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.44 approaching $1 threshold
🔔 Track QNCX — Get forecast alerts →
💹 Market Data
Market Cap$7.59M
Shares Outstanding5.57M
FloatN/A
Cash$17.75M
Debt$18.36M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 14.18M shares
#1 Nantahala Capital Management, LLC 2.67M shares
#2 Adage Capital Partners GP L.L.C. 2.25M shares
#3 Vanguard Group Inc 2.08M shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest13.83M
Days to Cover1.0
% of FloatN/A
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2019
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track QNCX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QNCX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required